Managing partner and executive creative director Nina Manasan Greenberg believes reemphasizing this mantra generates results and maintains morale. For example, every Friday the agency conducts an information-sharing and training session called Access Animals, during which staffers share their expertise. Presenters aren’t always old-timers or higher-ups, Greenberg reports, and that’s a good thing.
“One of our writers, who has only been working in managed markets for about 18 months, had to write a piece on the Medicare Access and CHIP Reauthorization Act and ended up giving one of the funniest and thoughtful classes we’ve had. He managed to make MACRA and the Centers for Medicare and Medicaid Services hilarious,” she recalls.
The message sent by such group get-togethers and presentations? Every person in the organization has a responsibility not just to learn, but also to teach. This, Greenberg believes, creates a tighter, brighter team.
And, ostensibly, leads to stronger results. Entrée Health grew revenue from $27.1 million in 2016 to $29 million in 2017. Staff size also increased to 138.
In recent years, Entrée Health has strengthened its bonds with its Omnicom Health Group sibling agencies. “There was a deliberate effort two years ago to bring agencies together on behalf of providing more integrated solutions to clients,” explains Entrée president Andrew Gottfried. “That allows us to help them think in different ways about their business and form partnerships across our organization. It helps us think agnostically.”
One example: Entrée Health added an offering created with sister agency BioPharm Communications. “The platform looks at deep, individual psychographic profiles. We are able to tap into a million HCPs within our database segmented by local access,” Gottfried explains. “This helps clients get medicine to the patients who need it and [confirms] it’s available and reimbursed.”
Entrée introduced two other tools in 2017: a payer offering developed with sister agency Adelphi and Market Access Research: Comprehensive Opinions.
Execs believe these tools have fueled new growth from existing and would-be clients. Entrée Health started working with Genentech as AOR on the launch of hemophilia A drug Hemlibra, which led to assignments on idiopathic pulmonary fibrosis drug Esbriet and Genentech and Novartis asthma drug Xolair.